Elligo Health Research

What Elligo Health Research does

Elligo Health Research, founded in 2016 and headquartered in Austin, Texas, is a privately held clinical research enablement company that embeds clinical trials directly into real-world healthcare settings. The company operates four integrated service modules: the Elligo Site Network (40+ research-ready sites staffed and equipped by Elligo), Decentralized Clinical Trial solutions (virtual, hybrid, and traditional designs), Recruitment & Engagement (patient matching and outreach executed in 28 countries), and Travel & Logistics (concierge-level support delivered in 38+ countries with a reported 93% post-randomization retention rate). Underpinning these services is the IntElligo technology platform, which integrates with existing clinical workflows and provides patient matching capabilities, while the ResearchAsCare.com portal serves as the patient-facing entry point. Elligo claims access to 1.6 million patients through its site network and reports experience across 200+ clinical trials and 500+ decentralized, recruitment, and travel studies.

Elligo sells primarily to pharmaceutical sponsors and Contract Research Organizations (CROs) through direct enterprise sales, with secondary relationships with healthcare sites/physicians (who receive staffing, training, and technology to enable research at their locations) and patients (who participate at no cost through ResearchAsCare). Revenue is generated through professional-services fees for site activation, patient recruitment, decentralized trial execution, and travel/logistics support, with pricing tailored to individual study requirements and not publicly disclosed. The company has scaled through acquisitions of ePatientFinder (2018), Root Health (2021), and ClinEdge (2021, financed alongside a $135M Series E co-led by Morgan Stanley Expansion Capital and Ally Bridge Group), and added a $40M venture loan facility from Horizon Technology Finance in October 2023. Total disclosed funding is approximately $171M in equity plus $40M debt capacity. The company employs 251–500 staff and operates globally.

Name

Elligo Health Research

Legal name

Elligo Health Research, Inc.

Website

https://elligohealthresearch.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

101–250 employees

Short description

Elligo Health Research is a private, Austin-based clinical research enablement company that embeds trials into real-world healthcare via a 40+ site network, decentralized trial services, patient recruitment across 28 countries, and travel/logistics support serving pharmaceutical sponsors, CROs, healthcare sites, and patients.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)

akta.pro secondary industries

Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM), Clinical Trial Site Operations & Study Coordination (HLAGACAE), eCOA/ePRO/eDiary & Patient-Facing Data Collection (HLACAOAB)

Keywords

• Clinical trial services
• Decentralized clinical trials
• Patient recruitment solutions
• Site network management
• Clinical research enablement

Headquarters

HQ city

Austin

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Site Network Services: Elligo provides access to its network of research-ready healthcare sites, offering comprehensive support including staffing, training, and technology integration. Revenue is generated through service fees for site activation and ongoing operational support provided to sponsors and CROs.
2. Patient Recruitment & Engagement Services: Patient recruitment solutions that blend global reach with local engagement, including outreach, study branding, bilingual pre-screening, and site support. Services are customized to align with protocols, sites, and participants across campaigns executed in 28 countries.
3. Travel & Logistics Services: Concierge-level travel support, fast reimbursements, and streamlined stipends to reduce participant burden and improve retention. Services are delivered in 38+ countries with a 93% post-randomization retention rate.
4. Decentralized Clinical Trial Solutions: Flexible trial solutions for virtual, hybrid and traditional trials with centralized oversight and data-powered recruitment. Provides sponsors and CROs with adaptable frameworks to maximize study success.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Elligo Health Research provides clinical trial enabling services through a network of research-ready healthcare sites embedded in real-world care settings. The company offers site network access, decentralized clinical trial execution, patient recruitment and engagement, and travel and logistics support to pharmaceutical sponsors, CROs, healthcare sites, and patients. Its IntElligo platform and ResearchAsCare patient portal enable end-to-end clinical research solutions across more than 28 countries.

Product overview

Elligo Health Research offers a unified clinical trial platform with four integrated service modules: the Elligo Site Network (research-ready sites embedded in healthcare), Decentralized Clinical Trials (virtual, hybrid, and traditional solutions), Recruitment & Engagement (patient matching and outreach across 28 countries), and Travel & Logistics (concierge support and retention services in 38+ countries). These are accessible through the IntElligo platform and supplemented by the patient-facing ResearchAsCare.com portal, together providing end-to-end clinical research enabling services for sponsors, CROs, sites, and patients.

Differentiator

Problem solved

Functional benefit

Brands

• IntElligo: Technology platform for sponsors and CROs to access clinical trial management and patient matching services.
• ResearchAsCare

Products and services

• Elligo Site Network Network of research-ready clinical sites embedded in real-world healthcare settings, providing staffing, training, and technology integrated with existing clinical workflows to enable patient access through everyday healthcare. Serves sponsors, CROs, and participating healthcare sites.
• Decentralized Clinical Trials

Quantifiable outcome

• 1.6 million patients available through site network
• +4 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature3 records

Partnerships

One partnership is on record.

• ClinEdgemajorStrategic or Co-development Partner · 24 September 2021Elligo Health Research acquired ClinEdge in September 2021 as part of its Series E funding. The acquisition formed a large healthcare research organization aimed at creating the largest end-to-end healthcare-enabling research entity, expanding clinical trial participation and access for underrepresented communities.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Syneos Health: Full-service CRO with growing decentralized clinical trial capabilities and biopharmaceutical services. Syneos is also an Elligo investor, making it both a comparable and a strategic partner across site activation, patient recruitment, and DCT delivery.
• Science 37: Pure-play decentralized clinical trial operator with a patient-centric, technology-enabled site-less trial model. Direct overlap with Elligo's decentralized and hybrid trial services and patient recruitment focus.
• Medable: Technology platform for decentralized clinical trials, providing eCOA, eConsent, telehealth, and patient-facing apps. Comparable to Elligo's IntElligo platform and ResearchAsCare patient portal in enabling DCT execution.
• Medpace: Mid-to-large full-service CRO with strong site management and clinical operations. Comparable to Elligo in therapeutic-area-focused trial execution, though Medpace operates a more traditional site-based model without Elligo's DCT emphasis.

Broad incumbents

• IQVIA: Largest global CRO and healthcare data company offering full-service clinical operations, real-world evidence, and DCT enablement. Competes with Elligo on enterprise sponsor relationships, with vastly broader scale and a more established DCT offering.
• ICON plc: Top-tier global CRO providing full-service clinical research, site management, and decentralized trial services post-PRA Health Sciences acquisition. Broad incumbent comparable in scale and end-to-end service model.
• Fortrea (formerly Labcorp Drug Development / Covance): Large CRO spun out from Labcorp providing clinical development, site management, and patient recruitment services. Comparable as an incumbent full-service CRO competing for sponsor and CRO outsourcing budgets alongside Elligo.

Emerging players

• Curebase: Decentralized clinical trial platform focused on enabling in-home and community-based trials with a site network model similar in philosophy to Elligo. Emerging competitor in the same DCT/site-enablement niche.
• Walgreens Clinical Trials: Retail pharmacy-led initiative embedding clinical research into community pharmacies and routine patient care. Highly analogous business model to Elligo's "research as part of everyday care" thesis, leveraging physical footprint and patient access.

Others

• Veeva Systems: Cloud software provider for life sciences including CTMS, eTMF, and clinical data management. Comparable as an enabling technology vendor whose products intersect with the workflow layers Elligo addresses via its IntElligo platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/elligo-health-research
• Xx.com/ElligoHealth

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Subsidiaries1 record

Funding overview

Funding rounds6 records

Investors13 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Elligo Health Research